Literature DB >> 23135271

PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation.

Louise Valentin-Hansen1, Birgitte Holst, Thomas M Frimurer, Thue W Schwartz.   

Abstract

In seven-transmembrane (7TM), G protein-coupled receptors, highly conserved residues function as microswitches, which alternate between different conformations and interaction partners in an extended allosteric interface between the transmembrane segments performing the large scale conformational changes upon receptor activation. Computational analysis using x-ray structures of the β(2)-adrenergic receptor demonstrated that PheVI:09 (6.44), which in the inactive state is locked between the backbone and two hydrophobic residues in transmembrane (TM)-III, upon activation slides ∼2 Å toward TM-V into a tight pocket generated by five hydrophobic residues protruding from TM-III and TM-V. Of these, the residue in position III:16 (3.40) (often an Ile or Val) appears to function as a barrier or gate for the transition between inactive and active conformation. Mutational analysis showed that PheVI:09 is essential for the constitutive and/or agonist-induced signaling of the ghrelin receptor, GPR119, the β(2)-adrenergic receptor, and the neurokinin-1 receptor. Substitution of the residues constituting the hydrophobic pocket between TM-III and TM-V in the ghrelin receptor in four of five positions impaired receptor signaling. In GPR39, representing the 12% of 7TM receptors lacking an aromatic residue at position VI:09, unchanged agonist-induced signaling was observed upon Ala substitution of LeuVI:09 despite reduced cell surface expression of the mutant receptor. It is concluded that PheVI:09 constitutes an aromatic microswitch that stabilizes the active, outward tilted conformation of TM-VI relative to TM-III by sliding into a tight hydrophobic pocket between TM-III and TM-V and that the hydrophobic residue in position III:16 constitutes a gate for this transition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135271      PMCID: PMC3527938          DOI: 10.1074/jbc.M112.395137

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.

Authors:  T J Baranski; P Herzmark; O Lichtarge; B O Gerber; J Trueheart; E C Meng; T Iiri; S P Sheikh; H R Bourne
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

2.  Normal modes for predicting protein motions: a comprehensive database assessment and associated Web tool.

Authors:  Vadim Alexandrov; Ursula Lehnert; Nathaniel Echols; Duncan Milburn; Donald Engelman; Mark Gerstein
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

Review 3.  Molecular mechanism of 7TM receptor activation--a global toggle switch model.

Authors:  Thue W Schwartz; Thomas M Frimurer; Birgitte Holst; Mette M Rosenkilde; Christian E Elling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

4.  Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.

Authors:  A Jagerschmidt; N Guillaume; B P Roques; F Noble
Journal:  Mol Pharmacol       Date:  1998-05       Impact factor: 4.436

5.  Identification of a ligand-dependent switch within a muscarinic receptor.

Authors:  T A Spalding; E S Burstein; S C Henderson; K R Ducote; M R Brann
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

6.  An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor.

Authors:  Eneko Urizar; Sylvie Claeysen; Xavier Deupí; Cedric Govaerts; Sabine Costagliola; Gilbert Vassart; Leonardo Pardo
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

7.  Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor.

Authors:  B Holst; S Zoffmann; C E Elling; S A Hjorth; T W Schwartz
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

8.  The effects of amino acid replacements of glycine 121 on transmembrane helix 3 of rhodopsin.

Authors:  M Han; S W Lin; S O Smith; T P Sakmar
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

9.  Mutations of the DRY motif that preserve beta 2-adrenoceptor coupling.

Authors:  A Seibold; M Dagarag; M Birnbaumer
Journal:  Receptors Channels       Date:  1998

10.  The arginine of the DRY motif in transmembrane segment III functions as a balancing micro-switch in the activation of the β2-adrenergic receptor.

Authors:  Louise Valentin-Hansen; Marleen Groenen; Rie Nygaard; Thomas M Frimurer; Nicholas D Holliday; Thue W Schwartz
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

View more
  15 in total

1.  Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.

Authors:  Andrii Ishchenko; Daniel Wacker; Mili Kapoor; Ai Zhang; Gye Won Han; Shibom Basu; Nilkanth Patel; Marc Messerschmidt; Uwe Weierstall; Wei Liu; Vsevolod Katritch; Bryan L Roth; Raymond C Stevens; Vadim Cherezov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.

Authors:  Alaa Abdul-Ridha; Laura López; Peter Keov; David M Thal; Shailesh N Mistry; Patrick M Sexton; J Robert Lane; Meritxell Canals; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

3.  Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag.

Authors:  Oleg G Chepurny; Daniela Bertinetti; Mandy Diskar; Colin A Leech; Parisa Afshari; Tamara Tsalkova; Xiaodong Cheng; Frank Schwede; Hans-G Genieser; Friedrich W Herberg; George G Holz
Journal:  Mol Endocrinol       Date:  2013-06-24

4.  Uncovering the triggers for GPCR activation using solid-state NMR spectroscopy.

Authors:  Naoki Kimata; Philip J Reeves; Steven O Smith
Journal:  J Magn Reson       Date:  2015-04       Impact factor: 2.229

Review 5.  Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster.

Authors:  Caline S Karam; Sandra K Jones; Jonathan A Javitch
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-07-09       Impact factor: 4.080

6.  Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).

Authors:  A Steen; A H Sparre-Ulrich; S Thiele; D Guo; T M Frimurer; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Structural Model of Ghrelin Bound to its G Protein-Coupled Receptor.

Authors:  Brian Joseph Bender; Gerrit Vortmeier; Stefan Ernicke; Mathias Bosse; Anette Kaiser; Sylvia Els-Heindl; Ulrike Krug; Annette Beck-Sickinger; Jens Meiler; Daniel Huster
Journal:  Structure       Date:  2019-01-24       Impact factor: 5.006

8.  Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.

Authors:  Tao Che; Susruta Majumdar; Saheem A Zaidi; Pauline Ondachi; John D McCorvy; Sheng Wang; Philip D Mosier; Rajendra Uprety; Eyal Vardy; Brian E Krumm; Gye Won Han; Ming-Yue Lee; Els Pardon; Jan Steyaert; Xi-Ping Huang; Ryan T Strachan; Alexandra R Tribo; Gavril W Pasternak; F Ivy Carroll; Raymond C Stevens; Vadim Cherezov; Vsevolod Katritch; Daniel Wacker; Bryan L Roth
Journal:  Cell       Date:  2018-01-04       Impact factor: 41.582

9.  G Protein-Coupled Receptors Contain Two Conserved Packing Clusters.

Authors:  Omar B Sanchez-Reyes; Aidan L G Cooke; Dale B Tranter; Dawood Rashid; Markus Eilers; Philip J Reeves; Steven O Smith
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 3.699

10.  GHS-R1a constitutive activity and its physiological relevance.

Authors:  Yves Mear; Alain Enjalbert; Sylvie Thirion
Journal:  Front Neurosci       Date:  2013-05-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.